Indian pharma firm Lupin pulls back 16,000 bottles of TB drug from US markets over manufacturing defects
Shortpedia
Content Team
Image Credit: economic times
Although an anti-trust lawsuit against Dr Reddy's was dismissed by a US court, another Indian pharma major has been forced to pull back its drugs from American markets. Indian pharma major Lupin has recalled more than 16,000 bottles of its tuberculosis drug Rifampin over possible side effects. The firm failed to specify impurities, which are supposed to be spotted during substance testing for long term stability.
